Evaluation of the Effect of Minimally Invasive Procedures Used in Management of Salivary Ductal Pathologies on Patients' Symptomatology and Gland Function

Sponsor
Aya Sakr (Other)
Overall Status
Completed
CT.gov ID
NCT05346341
Collaborator
(none)
31
1
1
13.2
2.3

Study Details

Study Description

Brief Summary

Aim of the current study was to evaluate the minimally invasive techniques in the management of salivary gland ductal pathologies

Condition or Disease Intervention/Treatment Phase
  • Procedure: Minimally invasive techniques
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Effect of Minimally Invasive Procedures Used in Management of Salivary Ductal Pathologies on Patients' Symptomatology and Gland Function - A Clinical Trial
Actual Study Start Date :
Feb 11, 2021
Actual Primary Completion Date :
Feb 10, 2022
Actual Study Completion Date :
Mar 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Minimally invasive techniques

Procedure: Minimally invasive techniques
All patient will be treated under general anaesthesia An appropriate gland-preserving minimally-invasive surgical procedure will be performed for all patients according to the nature and extent of the disease for either submandibular or parotid ducts. Minimally invasive techniques for ductal salivary gland pathologies include: Sialolithotomy through a simple cutdown Sialendoscopy Transoral microscopic-assisted sialolithotomy.

Outcome Measures

Primary Outcome Measures

  1. Subjective salivary gland performance [up to 12 months]

    This was done using a questionnaire to measure salivary score (this questionnaire is formulated by the multidisciplinary salivary gland society "MSGS"). The questionnaire consists of 20 questions divided in two groups: 13 regarding xerostomia and 7 regarding sialadenitis. Each question is scored from 0 to 10 and the total score could vary from 0 to 200 points.

  2. Objective salivary gland performance (salivary flow measurement) [up to 12 months]

    We have chosen 6 minutes as our standard time to collect saliva and we have chosen on purpose to collect saliva separately from the two parotids and jointly from the submandibular gland. A 5cmx5cm gaze is applied on the papilla of each Stenson duct and a third one is placed under the tongue. All these tampons are weighted separately after 6 minutes and the results collected.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients manifesting with either submandibular or parotid salivary gland ductal pathologies including:

  • Sialolithiasis (salivary stones).

  • Salivary ductal stenosis or stricture.

  • Children with juvenile recurrent parotitis.

  • Sjogren's syndrome.

  • Radio-iodine induced sialadenitis.

Exclusion Criteria:
  • Patients who are unfit for surgery.

  • Patients with previous submandibular or parotid surgical resection.

  • Patients with salivary tumors either benign or malignant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry, Alexandria University Alexandria Egypt 21527

Sponsors and Collaborators

  • Aya Sakr

Investigators

  • Principal Investigator: Aya Sakr, M.Sc, Faculty of Dentistry, Alexandria University, Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aya Sakr, Assistant Lecturer of Oral and Maxillofacial Surgery, Alexandria University
ClinicalTrials.gov Identifier:
NCT05346341
Other Study ID Numbers:
  • 00010556 - 0008839
First Posted:
Apr 26, 2022
Last Update Posted:
Apr 26, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 26, 2022